2022
DOI: 10.3389/fmicb.2022.1043596
|View full text |Cite
|
Sign up to set email alerts
|

Development of real-time and lateral flow recombinase polymerase amplification assays for rapid detection of Schistosoma mansoni

Abstract: BackgroundAccurate diagnosis followed by timely treatment is an effective strategy for the prevention of complications together with reducing schistosomiasis transmission. Recombinase Polymerase Amplification (RPA) is a simple, rapid, sensitive, and specific isothermal method with low resource needs. This research aimed at the development and optimisation of a real-time (RT) and a lateral flow (LF) RPA assay for the detection of Schistosoma mansoni.MethodologyRecombinase Polymerase Amplification reactions were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 76 publications
(102 reference statements)
0
6
0
Order By: Relevance
“…Potential target genes include the mitochondrial NADH dehydrogenase 1 ( nad1 ) and the SjR2 retrotransposon for S. japonicum , 60 and the mitochondrial minisatellite DNA region (SmMIT) for S. mansoni . 61 The SHERLOCK assay procedure could be streamlined by combining the RPA reaction with Cas13a detection (Cas13a protein, crRNA and reporter) in one single reaction (one-pot detection). This would simplify the protocol, improving ease-of-use and reducing processing time, as well as reducing the risk of introducing contaminants.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Potential target genes include the mitochondrial NADH dehydrogenase 1 ( nad1 ) and the SjR2 retrotransposon for S. japonicum , 60 and the mitochondrial minisatellite DNA region (SmMIT) for S. mansoni . 61 The SHERLOCK assay procedure could be streamlined by combining the RPA reaction with Cas13a detection (Cas13a protein, crRNA and reporter) in one single reaction (one-pot detection). This would simplify the protocol, improving ease-of-use and reducing processing time, as well as reducing the risk of introducing contaminants.…”
Section: Discussionmentioning
confidence: 99%
“…Potential target genes include the mitochondrial NADH dehydrogenase 1 ( nad1 ) and the SjR2 retrotransposon for S. japonicum , 60 and the mitochondrial minisatellite DNA region (SmMIT) for S. mansoni . 61 …”
Section: Discussionmentioning
confidence: 99%
“…4 These methods have also been applied to Leishmaniasis and Schistosoma detection. 5,6 Monitoring treatment efficacy is another area that requires better POCT. Early or low-grade parasitic infections are frequently undetected by stool or urine microscopy.…”
Section: New Diagnostic Testsmentioning
confidence: 99%
“…Their sensitivities for detecting disease are promising; the estimated LAMP sensitivity for M. ulcerans is between 73.75% and 91.49% 4 . These methods have also been applied to Leishmaniasis and Schistosoma detection 5,6 …”
Section: New Diagnostic Testsmentioning
confidence: 99%
“…Improved coprological tests, such as the saline gradient method (9), formalin-ethyl acetate sedimentationdigestion (FEA-SD) (10) and Helmintex method (i.e., isolates eggs from fecal samples with the use of paramagnetic particles in a magnetic field) (11) showed an increased diagnostic sensitivity compared with the traditional techniques; yet are usually labour-intensive and have a lengthy processing time. In addition, polymerase chain reaction (PCR) technology-based molecular diagnostics, including real time quantitative (q)PCR- (12)(13)(14)(15), droplet digital (dd) PCR-based assays (16)(17)(18), loop-mediated isothermal amplification (LAMP) (19)(20)(21), and recombinase polymerase amplification (RPA) (22)(23)(24)(25) are alternative tools for schistosomiasis diagnosis due to their outstanding accuracy; however, these tests require experienced human resources and are expensive (e.g. the relatively high cost of DNA extraction, qPCR reagents and/or equipment), limiting their application in remote areas with limited resources.…”
Section: Introductionmentioning
confidence: 99%